Get the latest tech news
With Varda Space, leading Silicon Valley players make big bet on making drugs in space
Varda Space has been fueled with new capital to scale its in-space drug manufacturing business.
The company has raised a massive new round to turn space into the “ultimate high ground” for the production of critical pharmaceutical components that can be brought back to Earth and used to make finished drugs. The company’s $187 million Series C funding round announced Thursday will be used to build out a new laboratory facility that could transform Varda’s orbital manufacturing process into a lucrative intellectual property-generating machine. They will essentially perform “the upfront work” to determine which assets are good candidates for an orbital mission, and what conditions to put them through in space, Varda co-founder Delian Asparouhov explained in an interview with TechCrunch.
Or read this on TechCrunch